Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network.
about
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.Evaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates.Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan.Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada.Determination of trimethoprim-sulfamethoxazole resistance in Streptococcus pneumoniae by using the E test with Mueller-Hinton agar supplemented with sheep or horse blood may be unreliable. The Pneumococcal Study Group.Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2.Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE lociIn vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.The microbes strike back.Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.Antimicrobial resistance in Canada.Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002A cross-Canada surveillance of antimicrobial resistance in respiratory tract pathogensIn vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance studyAntibiotic resistance in Canada at the dawn of the new millennium - a model for the developed world?Routine adult immunization in Canada: recommendations and performance.Antimicrobial resistance - Judicious use is the keyAntibiotic-resistant Streptococcus pneumoniae. Implications for medical practice.In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae.Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000.Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations.
P2860
Q33593776-8A6A16C6-C86E-48D8-B442-072E8BB4CBB8Q33659832-149523FA-CB35-4A52-B84F-E9B69B527356Q33672446-E80610FB-95BB-4D8D-B3E3-CB1690603F28Q33946065-7CAEDB66-5AFB-4B7B-B773-35800236E9D9Q33958232-92B526AE-7D3C-4DAA-BBA7-0E3FABEEE4F3Q33968677-18EB5CCE-F8E9-42FD-B4C9-96502B143E39Q33976055-03B6F5F1-1A4C-43EC-825C-3AD1D384233BQ33977709-B9DE3F33-975C-481A-AADF-00BCFE0569EEQ33977884-DBEFB0D8-01DF-4001-ABD8-951C36ADBFB1Q34026955-BB95F3C6-2142-4D22-8E98-E87880233652Q34027404-36057A46-C530-4D7D-9391-C7C7B12EB915Q34107785-18B2C271-78EB-4488-AE6A-37DCABB517BFQ34133853-4C6FBF35-3B33-4EE9-BC6E-E92F1D72EC49Q35013962-BED229E4-1C94-473F-838D-0E94E75B45BDQ35649662-48CEA2DA-42DC-4298-BB06-8177C36F6EC7Q35649669-98C569DC-B12B-40F3-B12F-2F745BEF59AEQ36170230-4133EF61-F8A4-451F-8C70-8E496FDF20D7Q36170566-3CBA3C7E-034F-4747-8C84-C0E24A7F38EBQ36170892-6EF8C779-5A2E-4D65-847B-C7459A1D58F8Q36515266-72CDE8D9-5D57-4D8E-9FA7-334220187D6FQ37488975-433476CA-66E5-43CE-8F73-0A751E4687FFQ39558038-A66FB8F6-D0E9-4092-B06F-E0C42B25D584Q39651028-FDA7C245-5F76-4C3B-9741-2760FCA34B3CQ39671236-A64AAE2C-1915-4ED3-BE16-A2B1B3A07FA0
P2860
Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network.
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Canadian national survey of pr ...... acterial Surveillance Network.
@ast
Canadian national survey of pr ...... acterial Surveillance Network.
@en
type
label
Canadian national survey of pr ...... acterial Surveillance Network.
@ast
Canadian national survey of pr ...... acterial Surveillance Network.
@en
prefLabel
Canadian national survey of pr ...... acterial Surveillance Network.
@ast
Canadian national survey of pr ...... acterial Surveillance Network.
@en
P2093
P2860
P1476
Canadian national survey of pr ...... acterial Surveillance Network.
@en
P2093
P2860
P304
P407
P577
1996-09-01T00:00:00Z